VERSO BIOSENSE R&D LIMITED

09890252
Active Abingdon

Activities of other holding companies n.e.c.

0 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
V

VERSO BIOSENSE R&D LIMITED

09890252

Activities of other holding companies n.e.c.

Founded 26 Nov 2015 Active Abingdon, United Kingdom 0 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.

Previous Company Names

VIVOPLEX ANIMAL HEALTH LIMITED 17 May 2019 — 1 May 2023
VIVOPLEX INDUSTRIAL LIMITED 6 Oct 2017 — 17 May 2019
VIVOPLEX LIMITED 26 Nov 2015 — 6 Oct 2017
Accounts Submitted 30 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 19 Dec 2025 Next due 9 Dec 2026 5 months remaining
Net assets £-11K £2K 2024 year on year
Total assets £80 £823K 2024 year on year
Total Liabilities £11K £821K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Milton Park Milton Abingdon Oxfordshire OX14 4RZ United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for VERSO BIOSENSE R&D LIMITED (09890252), an active life sciences and medical technology company based in Abingdon, United Kingdom. Incorporated 26 Nov 2015. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2016–2024)

Cash in Bank

£70.00

Increased by £52.00 (+289%)

Net Assets

-£11.15k

Decreased by £1.83k (-20%)

Total Liabilities

£11.23k

Decreased by £821.44k (-99%)

Turnover

N/A

Employees

N/A

Debt Ratio

14036%

Increased by 13935 (+13797%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Vivoplex Medical Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Notified 29 Aug 2017
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Charles Edward Dickson

Ceased 29 Aug 2017

Ceased

Group Structure

Group Structure

VERSO BIOSENSE R&D LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
14 May 2026OfficersTermination of Christopher John Dickson as director on 13 May 2026
14 May 2026OfficersTermination of James Duncan Dickson as director on 13 May 2026
14 May 2026OfficersTermination of Charles Edward Dickson as director on 13 May 2026
14 May 2026OfficersTermination of Helen Arthodia Dickson as director on 13 May 2026
19 Dec 2025Confirmation StatementConfirmation statement made on 25 Nov 2025 with no updates
14 May 2026 Officers

Termination of Christopher John Dickson as director on 13 May 2026

14 May 2026 Officers

Termination of James Duncan Dickson as director on 13 May 2026

14 May 2026 Officers

Termination of Charles Edward Dickson as director on 13 May 2026

14 May 2026 Officers

Termination of Helen Arthodia Dickson as director on 13 May 2026

19 Dec 2025 Confirmation Statement

Confirmation statement made on 25 Nov 2025 with no updates

Recent Activity

Latest Activity

Termination of Christopher John Dickson as director on 13 May 2026

1 months ago on 14 May 2026

Termination of James Duncan Dickson as director on 13 May 2026

1 months ago on 14 May 2026

Termination of Charles Edward Dickson as director on 13 May 2026

1 months ago on 14 May 2026

Termination of Helen Arthodia Dickson as director on 13 May 2026

1 months ago on 14 May 2026

Confirmation statement made on 25 Nov 2025 with no updates

6 months ago on 19 Dec 2025